EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in MCFA to ameliorate lipoatrophic hepatocyte injury and lipid metabolism disorders (Review)

Haibo Xu, Baogui Wang, Qi Wang, Chunlong Sun, Wen Du

Molecular Medicine Reports · 2025

DOI: 10.3892/mmr.2025.13593 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, 2025. Verfasst von Haibo Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Health and Elderly Care, Shandong Women's University, Jinan, Shandong 250000, P.R. China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Hepatocytes, Lipid Metabolism, Lipid Metabolism Disorders. Die Arbeit nennt 127 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the improvement in the material standard of living of individuals and a decrease in physical activity, which has led to a significant increase in the incidence of obesity and its related metabolic diseases, non‑alcoholic fatty liver disease (NAFLD) is increasingly becoming one of the more common metabolic disorders of the liver that threatens public health. Lipid deposits in the liver cause simple hepatic steatosis to develop into non‑alcoholic steatohepatitis (NASH), which causes severe damage to the organism; however, the key mechanisms responsible for the progression of NASH remain unclear. Therefore, the active and effective correction of the imbalance of energy metabolism in the organism is a common health challenge for humans. The present review summarized the research progress made on fatty acid biology, namely medium‑chain fatty acids (MCFAs) and the causes of the pathogenesis of NAFLD, the induction of apoptosis, oxidative stress, immune regulation and related lipid metabolism signaling pathways. The present review provided evidence supporting MCFAs as a potential therapeutic intervention for NAFLD by regulating lipid metabolism and reducing oxidative stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHepatocytesLipid MetabolismLipid Metabolism DisordersFatty AcidsHumansAnimalsOxidative StressSignal Transduction

Stichwörter der Autor:innen

inflammatory factorslipid metabolismmedium‑chain fatty acidsnon‑alcoholic fatty liver diseaseoxidative stress

Substanzen

Fatty Acids

Autor:innen und Institutionen

  • School of Health and Elderly Care, Shandong Women's University, Jinan, Shandong 250000, P.R. China.
  • Department of Biological and Environmental Engineering, Shandong University of Aviation, Binzhou, Shandong 256600, P.R. China.

Zitieren

APA

Xu, H., Wang, B., Wang, Q., Sun, C., & Du, W. (2025). Advances in MCFA to ameliorate lipoatrophic hepatocyte injury and lipid metabolism disorders (Review). Molecular Medicine Reports. https://doi.org/10.3892/mmr.2025.13593

Vancouver

Xu H, Wang B, Wang Q, Sun C, Du W. Advances in MCFA to ameliorate lipoatrophic hepatocyte injury and lipid metabolism disorders (Review). Molecular Medicine Reports. 2025. doi:10.3892/mmr.2025.13593

BibTeX
@article{Xu2025,
  author = {Xu, Haibo and Wang, Baogui and Wang, Qi and Sun, Chunlong and Du, Wen},
  title = {Advances in MCFA to ameliorate lipoatrophic hepatocyte injury and lipid metabolism disorders (Review)},
  journal = {Molecular Medicine Reports},
  year = {2025},
  doi = {10.3892/mmr.2025.13593}
}
Kostenlos starten →